John T. Kontor, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Kontor J.; Erythropoietin for Total Hip Joint Arthroplasty. Ann Intern Med. 2001;135:471. doi: 10.7326/0003-4819-135-6-200109180-00019
Download citation file:
Published: Ann Intern Med. 2001;135(6):471.
TO THE EDITOR:
The study by Feagan and colleagues (1) provides important information about the use of erythropoietin and iron to increase preoperative hemoglobin levels and avoid blood transfusions in orthopedic patients. Unfortunately, little evidence shows that transfusions for patients such as those in the study are necessary in the first place. Existing evidence suggests that transfusions for patients with postoperative hip replacements (2, 3) and noncardiac patients in the intensive care unit (4) with hemoglobin levels of 80 to 100 g/L are of no benefit and might actually be harmful. It would be of much greater use to see this study repeated using strict criteria for transfusion indications. We should also focus on educating primary care physicians and surgeons about the appropriate indications for transfusions. This may be a safer and more cost-effective approach to avoiding the unnecessary and potentially harmful use of blood products.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only